Early warrants call expected to bring in $10.4M for InVivo

05/7/2013 | MassDevice.com (Boston)

InVivo Therapeutics is poised to obtain $10.4 million from a call for early exercise of warrants it released to investors in 2010. The call could "eliminate a major impediment towards the up-listing of the company's stock to a national securities exchange," the spinal device company said in a release.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ